Market Intelligence chevron_right Pharma & Healthcare chevron_right Topical Hemostatic Agents
Global Report 2022

Global Topical Hemostatic Agents Market Insights, Forecast to 2031

calendar_todayPublished: Apr 2022 descriptionPages: 111 categoryCategory: Pharma & Healthcare
cloud_downloadRequest Sample Report
mailPre-Order Enquiry
local_offerGet Discount 
1 Study Coverage
    1.1 Topical Hemostatic Agents Product Introduction
    1.2 Market by Type
        1.2.1 Global Topical Hemostatic Agents Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Gelation Sponge
        1.2.3 Oxidized Regenerated Cellulose Based Hemostats
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Topical Hemostatic Agents Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Surgical Centers
        1.3.4 Nursing Homes
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Topical Hemostatic Agents Sales Estimates and Forecasts 2017-2028
    2.2 Global Topical Hemostatic Agents Revenue Estimates and Forecasts 2017-2028
    2.3 Global Topical Hemostatic Agents Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Topical Hemostatic Agents Sales by Region
        2.4.1 Global Topical Hemostatic Agents Sales by Region (2017-2022)
        2.4.2 Global Sales Topical Hemostatic Agents by Region (2023-2028)
    2.5 Global Topical Hemostatic Agents Revenue by Region
        2.5.1 Global Topical Hemostatic Agents Revenue by Region (2017-2022)
        2.5.2 Global Topical Hemostatic Agents Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Topical Hemostatic Agents Sales by Manufacturers
        3.1.1 Global Top Topical Hemostatic Agents Manufacturers by Sales (2017-2022)
        3.1.2 Global Topical Hemostatic Agents Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Topical Hemostatic Agents in 2021
    3.2 Global Topical Hemostatic Agents Revenue by Manufacturers
        3.2.1 Global Topical Hemostatic Agents Revenue by Manufacturers (2017-2022)
        3.2.2 Global Topical Hemostatic Agents Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Topical Hemostatic Agents Revenue in 2021
    3.3 Global Topical Hemostatic Agents Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Topical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Topical Hemostatic Agents Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Topical Hemostatic Agents Sales by Type
        4.1.1 Global Topical Hemostatic Agents Historical Sales by Type (2017-2022)
        4.1.2 Global Topical Hemostatic Agents Forecasted Sales by Type (2023-2028)
        4.1.3 Global Topical Hemostatic Agents Sales Market Share by Type (2017-2028)
    4.2 Global Topical Hemostatic Agents Revenue by Type
        4.2.1 Global Topical Hemostatic Agents Historical Revenue by Type (2017-2022)
        4.2.2 Global Topical Hemostatic Agents Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Topical Hemostatic Agents Revenue Market Share by Type (2017-2028)
    4.3 Global Topical Hemostatic Agents Price by Type
        4.3.1 Global Topical Hemostatic Agents Price by Type (2017-2022)
        4.3.2 Global Topical Hemostatic Agents Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Topical Hemostatic Agents Sales by Application
        5.1.1 Global Topical Hemostatic Agents Historical Sales by Application (2017-2022)
        5.1.2 Global Topical Hemostatic Agents Forecasted Sales by Application (2023-2028)
        5.1.3 Global Topical Hemostatic Agents Sales Market Share by Application (2017-2028)
    5.2 Global Topical Hemostatic Agents Revenue by Application
        5.2.1 Global Topical Hemostatic Agents Historical Revenue by Application (2017-2022)
        5.2.2 Global Topical Hemostatic Agents Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Topical Hemostatic Agents Revenue Market Share by Application (2017-2028)
    5.3 Global Topical Hemostatic Agents Price by Application
        5.3.1 Global Topical Hemostatic Agents Price by Application (2017-2022)
        5.3.2 Global Topical Hemostatic Agents Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Topical Hemostatic Agents Market Size by Type
        6.1.1 North America Topical Hemostatic Agents Sales by Type (2017-2028)
        6.1.2 North America Topical Hemostatic Agents Revenue by Type (2017-2028)
    6.2 North America Topical Hemostatic Agents Market Size by Application
        6.2.1 North America Topical Hemostatic Agents Sales by Application (2017-2028)
        6.2.2 North America Topical Hemostatic Agents Revenue by Application (2017-2028)
    6.3 North America Topical Hemostatic Agents Market Size by Country
        6.3.1 North America Topical Hemostatic Agents Sales by Country (2017-2028)
        6.3.2 North America Topical Hemostatic Agents Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Topical Hemostatic Agents Market Size by Type
        7.1.1 Europe Topical Hemostatic Agents Sales by Type (2017-2028)
        7.1.2 Europe Topical Hemostatic Agents Revenue by Type (2017-2028)
    7.2 Europe Topical Hemostatic Agents Market Size by Application
        7.2.1 Europe Topical Hemostatic Agents Sales by Application (2017-2028)
        7.2.2 Europe Topical Hemostatic Agents Revenue by Application (2017-2028)
    7.3 Europe Topical Hemostatic Agents Market Size by Country
        7.3.1 Europe Topical Hemostatic Agents Sales by Country (2017-2028)
        7.3.2 Europe Topical Hemostatic Agents Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Topical Hemostatic Agents Market Size by Type
        8.1.1 Asia Pacific Topical Hemostatic Agents Sales by Type (2017-2028)
        8.1.2 Asia Pacific Topical Hemostatic Agents Revenue by Type (2017-2028)
    8.2 Asia Pacific Topical Hemostatic Agents Market Size by Application
        8.2.1 Asia Pacific Topical Hemostatic Agents Sales by Application (2017-2028)
        8.2.2 Asia Pacific Topical Hemostatic Agents Revenue by Application (2017-2028)
    8.3 Asia Pacific Topical Hemostatic Agents Market Size by Region
        8.3.1 Asia Pacific Topical Hemostatic Agents Sales by Region (2017-2028)
        8.3.2 Asia Pacific Topical Hemostatic Agents Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Topical Hemostatic Agents Market Size by Type
        9.1.1 Latin America Topical Hemostatic Agents Sales by Type (2017-2028)
        9.1.2 Latin America Topical Hemostatic Agents Revenue by Type (2017-2028)
    9.2 Latin America Topical Hemostatic Agents Market Size by Application
        9.2.1 Latin America Topical Hemostatic Agents Sales by Application (2017-2028)
        9.2.2 Latin America Topical Hemostatic Agents Revenue by Application (2017-2028)
    9.3 Latin America Topical Hemostatic Agents Market Size by Country
        9.3.1 Latin America Topical Hemostatic Agents Sales by Country (2017-2028)
        9.3.2 Latin America Topical Hemostatic Agents Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Topical Hemostatic Agents Market Size by Type
        10.1.1 Middle East and Africa Topical Hemostatic Agents Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Topical Hemostatic Agents Revenue by Type (2017-2028)
    10.2 Middle East and Africa Topical Hemostatic Agents Market Size by Application
        10.2.1 Middle East and Africa Topical Hemostatic Agents Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Topical Hemostatic Agents Revenue by Application (2017-2028)
    10.3 Middle East and Africa Topical Hemostatic Agents Market Size by Country
        10.3.1 Middle East and Africa Topical Hemostatic Agents Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Topical Hemostatic Agents Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Ethicon
        11.1.1 Ethicon Corporation Information
        11.1.2 Ethicon Overview
        11.1.3 Ethicon Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Ethicon Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Ethicon Recent Developments
    11.2 Pfizer
        11.2.1 Pfizer Corporation Information
        11.2.2 Pfizer Overview
        11.2.3 Pfizer Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Pfizer Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Pfizer Recent Developments
    11.3 Baxter International
        11.3.1 Baxter International Corporation Information
        11.3.2 Baxter International Overview
        11.3.3 Baxter International Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Baxter International Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Baxter International Recent Developments
    11.4 C. R. Bard
        11.4.1 C. R. Bard Corporation Information
        11.4.2 C. R. Bard Overview
        11.4.3 C. R. Bard Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 C. R. Bard Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 C. R. Bard Recent Developments
    11.5 The Medicines Company
        11.5.1 The Medicines Company Corporation Information
        11.5.2 The Medicines Company Overview
        11.5.3 The Medicines Company Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 The Medicines Company Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 The Medicines Company Recent Developments
    11.6 Anika Therapeutics
        11.6.1 Anika Therapeutics Corporation Information
        11.6.2 Anika Therapeutics Overview
        11.6.3 Anika Therapeutics Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Anika Therapeutics Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Anika Therapeutics Recent Developments
    11.7 Advanced Medical Solutions
        11.7.1 Advanced Medical Solutions Corporation Information
        11.7.2 Advanced Medical Solutions Overview
        11.7.3 Advanced Medical Solutions Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Advanced Medical Solutions Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Advanced Medical Solutions Recent Developments
    11.8 Integra LifeSciences
        11.8.1 Integra LifeSciences Corporation Information
        11.8.2 Integra LifeSciences Overview
        11.8.3 Integra LifeSciences Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Integra LifeSciences Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Integra LifeSciences Recent Developments
    11.9 B Braun Melsungen
        11.9.1 B Braun Melsungen Corporation Information
        11.9.2 B Braun Melsungen Overview
        11.9.3 B Braun Melsungen Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 B Braun Melsungen Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 B Braun Melsungen Recent Developments
    11.10 Gelita Medical
        11.10.1 Gelita Medical Corporation Information
        11.10.2 Gelita Medical Overview
        11.10.3 Gelita Medical Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Gelita Medical Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Gelita Medical Recent Developments
    11.11 Equimedical
        11.11.1 Equimedical Corporation Information
        11.11.2 Equimedical Overview
        11.11.3 Equimedical Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Equimedical Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Equimedical Recent Developments
    11.12 Vascular Solutions
        11.12.1 Vascular Solutions Corporation Information
        11.12.2 Vascular Solutions Overview
        11.12.3 Vascular Solutions Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Vascular Solutions Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Vascular Solutions Recent Developments
    11.13 Marine Polymer Technologies
        11.13.1 Marine Polymer Technologies Corporation Information
        11.13.2 Marine Polymer Technologies Overview
        11.13.3 Marine Polymer Technologies Topical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Marine Polymer Technologies Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Marine Polymer Technologies Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Topical Hemostatic Agents Industry Chain Analysis
    12.2 Topical Hemostatic Agents Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Topical Hemostatic Agents Production Mode & Process
    12.4 Topical Hemostatic Agents Sales and Marketing
        12.4.1 Topical Hemostatic Agents Sales Channels
        12.4.2 Topical Hemostatic Agents Distributors
    12.5 Topical Hemostatic Agents Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Topical Hemostatic Agents Industry Trends
    13.2 Topical Hemostatic Agents Market Drivers
    13.3 Topical Hemostatic Agents Market Challenges
    13.4 Topical Hemostatic Agents Market Restraints
14 Key Findings in The Global Topical Hemostatic Agents Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Topical Hemostatic Agents Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Gelation Sponge
    Table 3. Major Manufacturers of Oxidized Regenerated Cellulose Based Hemostats
    Table 4. Major Manufacturers of Others
    Table 5. Global Topical Hemostatic Agents Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Topical Hemostatic Agents Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Topical Hemostatic Agents Sales by Region (2017-2022) & (K Units)
    Table 8. Global Topical Hemostatic Agents Sales Market Share by Region (2017-2022)
    Table 9. Global Topical Hemostatic Agents Sales by Region (2023-2028) & (K Units)
    Table 10. Global Topical Hemostatic Agents Sales Market Share by Region (2023-2028)
    Table 11. Global Topical Hemostatic Agents Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Topical Hemostatic Agents Revenue Market Share by Region (2017-2022)
    Table 13. Global Topical Hemostatic Agents Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Topical Hemostatic Agents Revenue Market Share by Region (2023-2028)
    Table 15. Global Topical Hemostatic Agents Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Topical Hemostatic Agents Sales Share by Manufacturers (2017-2022)
    Table 17. Global Topical Hemostatic Agents Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Topical Hemostatic Agents Revenue Share by Manufacturers (2017-2022)
    Table 19. Topical Hemostatic Agents Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Topical Hemostatic Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Topical Hemostatic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Topical Hemostatic Agents as of 2021)
    Table 22. Topical Hemostatic Agents Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Topical Hemostatic Agents Product Offered
    Table 24. Date of Manufacturers Enter into Topical Hemostatic Agents Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Topical Hemostatic Agents Sales by Type (2017-2022) & (K Units)
    Table 27. Global Topical Hemostatic Agents Sales by Type (2023-2028) & (K Units)
    Table 28. Global Topical Hemostatic Agents Sales Share by Type (2017-2022)
    Table 29. Global Topical Hemostatic Agents Sales Share by Type (2023-2028)
    Table 30. Global Topical Hemostatic Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Topical Hemostatic Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Topical Hemostatic Agents Revenue Share by Type (2017-2022)
    Table 33. Global Topical Hemostatic Agents Revenue Share by Type (2023-2028)
    Table 34. Topical Hemostatic Agents Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Topical Hemostatic Agents Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Topical Hemostatic Agents Sales by Application (2017-2022) & (K Units)
    Table 37. Global Topical Hemostatic Agents Sales by Application (2023-2028) & (K Units)
    Table 38. Global Topical Hemostatic Agents Sales Share by Application (2017-2022)
    Table 39. Global Topical Hemostatic Agents Sales Share by Application (2023-2028)
    Table 40. Global Topical Hemostatic Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Topical Hemostatic Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Topical Hemostatic Agents Revenue Share by Application (2017-2022)
    Table 43. Global Topical Hemostatic Agents Revenue Share by Application (2023-2028)
    Table 44. Topical Hemostatic Agents Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Topical Hemostatic Agents Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Topical Hemostatic Agents Sales by Type (2017-2022) & (K Units)
    Table 47. North America Topical Hemostatic Agents Sales by Type (2023-2028) & (K Units)
    Table 48. North America Topical Hemostatic Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Topical Hemostatic Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Topical Hemostatic Agents Sales by Application (2017-2022) & (K Units)
    Table 51. North America Topical Hemostatic Agents Sales by Application (2023-2028) & (K Units)
    Table 52. North America Topical Hemostatic Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Topical Hemostatic Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Topical Hemostatic Agents Sales by Country (2017-2022) & (K Units)
    Table 55. North America Topical Hemostatic Agents Sales by Country (2023-2028) & (K Units)
    Table 56. North America Topical Hemostatic Agents Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Topical Hemostatic Agents Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Topical Hemostatic Agents Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Topical Hemostatic Agents Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Topical Hemostatic Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Topical Hemostatic Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Topical Hemostatic Agents Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Topical Hemostatic Agents Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Topical Hemostatic Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Topical Hemostatic Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Topical Hemostatic Agents Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Topical Hemostatic Agents Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Topical Hemostatic Agents Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Topical Hemostatic Agents Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Topical Hemostatic Agents Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Topical Hemostatic Agents Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Topical Hemostatic Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Topical Hemostatic Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Topical Hemostatic Agents Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Topical Hemostatic Agents Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Topical Hemostatic Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Topical Hemostatic Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Topical Hemostatic Agents Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Topical Hemostatic Agents Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Topical Hemostatic Agents Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Topical Hemostatic Agents Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Topical Hemostatic Agents Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Topical Hemostatic Agents Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Topical Hemostatic Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Topical Hemostatic Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Topical Hemostatic Agents Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Topical Hemostatic Agents Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Topical Hemostatic Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Topical Hemostatic Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Topical Hemostatic Agents Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Topical Hemostatic Agents Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Topical Hemostatic Agents Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Topical Hemostatic Agents Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Topical Hemostatic Agents Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Topical Hemostatic Agents Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Topical Hemostatic Agents Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Topical Hemostatic Agents Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Topical Hemostatic Agents Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Topical Hemostatic Agents Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Topical Hemostatic Agents Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Topical Hemostatic Agents Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Topical Hemostatic Agents Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Topical Hemostatic Agents Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Topical Hemostatic Agents Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Topical Hemostatic Agents Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Ethicon Corporation Information
    Table 107. Ethicon Description and Major Businesses
    Table 108. Ethicon Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Ethicon Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Ethicon Recent Developments
    Table 111. Pfizer Corporation Information
    Table 112. Pfizer Description and Major Businesses
    Table 113. Pfizer Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Pfizer Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Pfizer Recent Developments
    Table 116. Baxter International Corporation Information
    Table 117. Baxter International Description and Major Businesses
    Table 118. Baxter International Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Baxter International Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Baxter International Recent Developments
    Table 121. C. R. Bard Corporation Information
    Table 122. C. R. Bard Description and Major Businesses
    Table 123. C. R. Bard Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. C. R. Bard Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. C. R. Bard Recent Developments
    Table 126. The Medicines Company Corporation Information
    Table 127. The Medicines Company Description and Major Businesses
    Table 128. The Medicines Company Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. The Medicines Company Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. The Medicines Company Recent Developments
    Table 131. Anika Therapeutics Corporation Information
    Table 132. Anika Therapeutics Description and Major Businesses
    Table 133. Anika Therapeutics Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Anika Therapeutics Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Anika Therapeutics Recent Developments
    Table 136. Advanced Medical Solutions Corporation Information
    Table 137. Advanced Medical Solutions Description and Major Businesses
    Table 138. Advanced Medical Solutions Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. Advanced Medical Solutions Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Advanced Medical Solutions Recent Developments
    Table 141. Integra LifeSciences Corporation Information
    Table 142. Integra LifeSciences Description and Major Businesses
    Table 143. Integra LifeSciences Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. Integra LifeSciences Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Integra LifeSciences Recent Developments
    Table 146. B Braun Melsungen Corporation Information
    Table 147. B Braun Melsungen Description and Major Businesses
    Table 148. B Braun Melsungen Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. B Braun Melsungen Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. B Braun Melsungen Recent Developments
    Table 151. Gelita Medical Corporation Information
    Table 152. Gelita Medical Description and Major Businesses
    Table 153. Gelita Medical Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 154. Gelita Medical Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Gelita Medical Recent Developments
    Table 156. Equimedical Corporation Information
    Table 157. Equimedical Description and Major Businesses
    Table 158. Equimedical Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 159. Equimedical Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. Equimedical Recent Developments
    Table 161. Vascular Solutions Corporation Information
    Table 162. Vascular Solutions Description and Major Businesses
    Table 163. Vascular Solutions Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 164. Vascular Solutions Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 165. Vascular Solutions Recent Developments
    Table 166. Marine Polymer Technologies Corporation Information
    Table 167. Marine Polymer Technologies Description and Major Businesses
    Table 168. Marine Polymer Technologies Topical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 169. Marine Polymer Technologies Topical Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 170. Marine Polymer Technologies Recent Developments
    Table 171. Key Raw Materials Lists
    Table 172. Raw Materials Key Suppliers Lists
    Table 173. Topical Hemostatic Agents Distributors List
    Table 174. Topical Hemostatic Agents Customers List
    Table 175. Topical Hemostatic Agents Market Trends
    Table 176. Topical Hemostatic Agents Market Drivers
    Table 177. Topical Hemostatic Agents Market Challenges
    Table 178. Topical Hemostatic Agents Market Restraints
    Table 179. Research Programs/Design for This Report
    Table 180. Key Data Information from Secondary Sources
    Table 181. Key Data Information from Primary Sources
List of Figures
    Figure 1. Topical Hemostatic Agents Product Picture
    Figure 3. Global Topical Hemostatic Agents Market Share by Type in 2021 & 2028
    Figure 3. Gelation Sponge Product Picture
    Figure 4. Oxidized Regenerated Cellulose Based Hemostats Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Topical Hemostatic Agents Market Share by Application in 2021 & 2028
    Figure 7. Hospitals
    Figure 8. Surgical Centers
    Figure 9. Nursing Homes
    Figure 10. Topical Hemostatic Agents Report Years Considered
    Figure 11. Global Topical Hemostatic Agents Sales 2017-2028 (K Units)
    Figure 12. Global Topical Hemostatic Agents Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Topical Hemostatic Agents Revenue 2017-2028 (US$ Million)
    Figure 14. Global Topical Hemostatic Agents Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Topical Hemostatic Agents Sales Market Share by Region (2017-2022)
    Figure 16. Global Topical Hemostatic Agents Sales Market Share by Region (2023-2028)
    Figure 17. North America Topical Hemostatic Agents Sales YoY (2017-2028) & (K Units)
    Figure 18. North America Topical Hemostatic Agents Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Topical Hemostatic Agents Sales YoY (2017-2028) & (K Units)
    Figure 20. Europe Topical Hemostatic Agents Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Topical Hemostatic Agents Sales YoY (2017-2028) & (K Units)
    Figure 22. Asia-Pacific Topical Hemostatic Agents Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Topical Hemostatic Agents Sales YoY (2017-2028) & (K Units)
    Figure 24. Latin America Topical Hemostatic Agents Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Topical Hemostatic Agents Sales YoY (2017-2028) & (K Units)
    Figure 26. Middle East & Africa Topical Hemostatic Agents Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Topical Hemostatic Agents Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Topical Hemostatic Agents in the World: Market Share by Topical Hemostatic Agents Revenue in 2021
    Figure 29. Global Topical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Topical Hemostatic Agents Sales Market Share by Type (2017-2028)
    Figure 31. Global Topical Hemostatic Agents Revenue Market Share by Type (2017-2028)
    Figure 32. Global Topical Hemostatic Agents Sales Market Share by Application (2017-2028)
    Figure 33. Global Topical Hemostatic Agents Revenue Market Share by Application (2017-2028)
    Figure 34. North America Topical Hemostatic Agents Sales Market Share by Type (2017-2028)
    Figure 35. North America Topical Hemostatic Agents Revenue Market Share by Type (2017-2028)
    Figure 36. North America Topical Hemostatic Agents Sales Market Share by Application (2017-2028)
    Figure 37. North America Topical Hemostatic Agents Revenue Market Share by Application (2017-2028)
    Figure 38. North America Topical Hemostatic Agents Sales Share by Country (2017-2028)
    Figure 39. North America Topical Hemostatic Agents Revenue Share by Country (2017-2028)
    Figure 40. U.S. Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Topical Hemostatic Agents Sales Market Share by Type (2017-2028)
    Figure 43. Europe Topical Hemostatic Agents Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Topical Hemostatic Agents Sales Market Share by Application (2017-2028)
    Figure 45. Europe Topical Hemostatic Agents Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Topical Hemostatic Agents Sales Share by Country (2017-2028)
    Figure 47. Europe Topical Hemostatic Agents Revenue Share by Country (2017-2028)
    Figure 48. Germany Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 49. France Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Topical Hemostatic Agents Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Topical Hemostatic Agents Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Topical Hemostatic Agents Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Topical Hemostatic Agents Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Topical Hemostatic Agents Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Topical Hemostatic Agents Revenue Share by Region (2017-2028)
    Figure 59. China Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 62. India Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Topical Hemostatic Agents Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Topical Hemostatic Agents Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Topical Hemostatic Agents Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Topical Hemostatic Agents Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Topical Hemostatic Agents Sales Share by Country (2017-2028)
    Figure 74. Latin America Topical Hemostatic Agents Revenue Share by Country (2017-2028)
    Figure 75. Mexico Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Topical Hemostatic Agents Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Topical Hemostatic Agents Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Topical Hemostatic Agents Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Topical Hemostatic Agents Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Topical Hemostatic Agents Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Topical Hemostatic Agents Revenue Share by Country (2017-2028)
    Figure 84. Turkey Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 86. U.A.E Topical Hemostatic Agents Revenue (2017-2028) & (US$ Million)
    Figure 87. Topical Hemostatic Agents Value Chain
    Figure 88. Topical Hemostatic Agents Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies

Frequently Asked Questions

What is the USP of the report? expand_more
Topical Hemostatic Agents report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Topical Hemostatic Agents report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Topical Hemostatic Agents report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.